Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-05-06 00:00:00 ET · period of report 2022-04-29 · accession 0001567619-22-009719 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-06 | 2022-04-29 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | A - Grant | $62.41 | +243 | 52.3K | +0.5% | +$15.2K | |
| 2022-05-06 | 2022-05-04 | BMRN | Guyer Charles Greg | EVP, Chief Technical Off | F - Tax | $84.65 | -3,926 | 48.4K | -8% | -$332.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-29 | A | A | 243 | $62.41 | 52,299 | D | — | — | (F1) Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2022-05-04 | F | D | 3,926 | $84.65 | 48,373 | D | — | — |